Senior Director, Clinical & Medical Affairs Bio-Techne
Join us for an engaging discussion with a top breast pathologist and a renowned breast oncologist on ESR1 mutation detection in advanced HR+/HER2- breast cancer. This interactive session will review the growing medical need for ESR1 mutation detection to inform treatment decisions. We will also cover pivotal clinical trials demonstrating the need for plasma-based ESR1 testing not only at progression but for monitoring while on therapy, and discuss new approaches for optimizing test sensitivity in liquid biopsy specimens. Pathologists and lab professionals seeking personalized approaches for HR+/HER2 breast cancer management can't miss this informative session.
